Close
Help
Need Help?



Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms

Submit a Paper


Libertas Analytics


1794 Article Views

Publication Date: 18 Mar 2009

Journal: Substance Abuse: Research and Treatment 2009:3 31-39

SART
journal

38,755 Article Views

3,256,705 Libertas Article Views

More Statistics

Abstract

Caroline L. Strasinger1, Nicole N. Scheff1, Ji Wu2, Bruce J. Hinds2 and Audra L. Stinchcomb1

1Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, U.S.A. 2Department of Chemical and Materials Engineering, University of Kentucky, Lexington, KY, U.S.A.

Abstract

Transdermal systems are attractive methods of drug administration specifically when treating patients for drug addiction. Current systems however are deficient in therapies that allow variable flux values of drug, such as nicotine for smoking cessation or complex dosing regimens using clonidine when treating opioid withdrawal symptoms. Through the use of functionalized carbon nanotube (CNT) membranes, drug delivery to the skin can be controlled by applying a small electrical bias to create a programmable drug delivery system. Clearly, a transdermal patch system that can be tailored to an individual’s needs will increase patient compliance as well as provide much more efficient therapy. The purpose of this paper is to discuss the applicability of using carbon nanotube membranes in transdermal systems for treatment of drug abuse.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES